# Safety and Efficacy Study of Regulatory T Cell Therapy in Liver Transplant Patients

> **NCT02166177** · PHASE1,PHASE2 · COMPLETED · sponsor: **Guy's and St Thomas' NHS Foundation Trust** · enrollment: 9 (actual)

## Conditions studied

- End-stage Liver Disease

## Interventions

- **DRUG:** Autologous regulatory T cell product

## Key facts

- **NCT ID:** NCT02166177
- **Lead sponsor:** Guy's and St Thomas' NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2018-01-22
- **Final completion:** 2018-01-22
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2019-01-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02166177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02166177, "Safety and Efficacy Study of Regulatory T Cell Therapy in Liver Transplant Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02166177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*